Ufp Technologies (UFPT) Capital Expenditures Growth (1y) (2011 - 2026)
Ufp Technologies (UFPT) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -43.42% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 27.22% |
| 10 | Ufp Technologies | 1.77 Bn | 1.75 Bn | 44.36 Mn | -38.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.02% |
| Sep 30, 2025 | -364.40% |
| Jun 30, 2025 | 3.10% |
| Mar 31, 2025 | 62.64% |
| Dec 31, 2024 | -224.64% |
| Sep 30, 2024 | -22.89% |
| Jun 30, 2024 | -0.04% |
| Mar 31, 2024 | -20.51% |
| Dec 31, 2023 | -7.02% |
| Sep 30, 2023 | 20.27% |
| Jun 30, 2023 | -55.06% |
| Mar 31, 2023 | -6.64% |
| Dec 31, 2022 | 165.12% |
| Sep 30, 2022 | 132.56% |
| Jun 30, 2022 | 236.50% |
| Mar 31, 2022 | 61.08% |
| Dec 31, 2021 | -14.72% |
| Sep 30, 2021 | 9.82% |
| Jun 30, 2021 | 62.07% |
| Mar 31, 2021 | 42.06% |